Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-M Samama

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Thrombosis Research|November 5, 2002
Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutationI Gouin-Thibault, R Arkam, S Nassiri, et al.
Thrombosis Research. Supplement|January 1, 1991
Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgeryM M Samama, S Combe, M H Horellou, et al.
Annales De Dermatologie Et De Venereologie|March 10, 2012
[Skin necrosis during long-term fluindione treatment revealing protein C deficiency]C Merklen-Djafri, I Mazurier, M-M Samama, et al.
Blood|August 15, 1993
Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiencyJ Conard, K A Bauer, A Gruber, et al.
The International Journal of Artificial Organs|December 1, 1994
An animal model for the evaluation of graft thrombosis in the acute phase on carbon-lined PTFE prosthesisG Babatasi, L Bara, F Galateau, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|June 1, 1993
Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM StudyP Y Scarabin, L Bara, S Ricard, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with ThrombocytosisG Cella, J Conard, S Manai, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 18, 1999
[New thrombolytic agents in myocardial infarction]G Helft, I Elalamy, F Beygui, et al.
The New England Journal of Medicine|September 9, 1999
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study GroupM M Samama, A T Cohen, J Y Darmon, et al.
Thrombosis Research|January 13, 2000
The heparin management test: a new device for monitoring anticoagulation during coronary interventionG Helft, P Bartolomeo, A G Zaman, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Thrombosis Research|November 5, 2002
Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutationI Gouin-Thibault, R Arkam, S Nassiri, et al.
Thrombosis Research. Supplement|January 1, 1991
Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgeryM M Samama, S Combe, M H Horellou, et al.
Annales De Dermatologie Et De Venereologie|March 10, 2012
[Skin necrosis during long-term fluindione treatment revealing protein C deficiency]C Merklen-Djafri, I Mazurier, M-M Samama, et al.
Blood|August 15, 1993
Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiencyJ Conard, K A Bauer, A Gruber, et al.
The International Journal of Artificial Organs|December 1, 1994
An animal model for the evaluation of graft thrombosis in the acute phase on carbon-lined PTFE prosthesisG Babatasi, L Bara, F Galateau, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|June 1, 1993
Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM StudyP Y Scarabin, L Bara, S Ricard, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with ThrombocytosisG Cella, J Conard, S Manai, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 18, 1999
[New thrombolytic agents in myocardial infarction]G Helft, I Elalamy, F Beygui, et al.
The New England Journal of Medicine|September 9, 1999
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study GroupM M Samama, A T Cohen, J Y Darmon, et al.
Thrombosis Research|January 13, 2000
The heparin management test: a new device for monitoring anticoagulation during coronary interventionG Helft, P Bartolomeo, A G Zaman, et al.
Pageof 19